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ABSTRACT We synthesized 3b-hydroxy-pregn-5-ene-21-(1-methylpyrenyl)-20-methylidene (Py-met-chol), consisting of
cholesterol steroid rings connected to a pyrene group via a linker without polar atoms. This compound has interesting
spectroscopic properties when probing membranes: 1), The pyrene has hypochromic properties resulting from probe self-
association processes in membranes. Using liposomes of various lipid compositions, we determined the association constants
of the probe (K): KDOPC KPOPC KDMPC. KDMPC/15 mol % Chol. KDMPC/30 mol % Chol. This indicates a better probe solvation in
saturated than in unsaturated lipids, and this effect is enhanced as the cholesterol concentration increases. 2), The pyrene
ﬂuorophore is characterized by monomer (I1–I5) and excimer (IE) emission bands. In model membranes, I1/I3 and IE/I3 ratios
revealed a correlation between the polarity of the lipid core of the membrane and the amount of cholesterol. 3), Using this probe,
we monitored the ﬁrst steps of the signaling pathway of the mouse d-opioid receptor, a G-protein-coupled receptor. The
thickness of the membrane around this receptor is known to change after agonist binding. Fluorescence spectra of living
Chinese hamster ovary cells overexpressing mouse d-opioid receptor speciﬁcally revealed the agonist binding. These results
indicate that Py-met-chol may be useful for screening ligands of this family of receptors.
INTRODUCTION
The plasma membrane is a complicated mixture of lipids and
proteins, organized into various specialized microdomains
(1), which differ in their composition, their physical proper-
ties, and, consequently, their biological functions (2,3). These
distinct microdomains cannot be directly identiﬁed in living
cells by noninvasive approaches. However, numerous studies
of detergent-resistant membrane fractions and of reconsti-
tuted model membranes of comparable lipid compositions
(4,5) indicate that some lipids have the propensity to associate
with each other and to promote lateral segregation (6). This
is the case for mixtures of cholesterol, sphingolipids, and sat-
urated glycerophospholipids, which generate a liquid-ordered
(lo) ﬂuid phase (2). This phase is characterized by more
tightly packed hydrophobic moieties, lipids having a weaker
translational diffusion and no rotational diffusion (2,3,7,8),
and a thicker membrane than the liquid-disordered (ld) phase
composed of unsaturated glycerophospholipids with the same
acyl chain lengths (9). Such lipid effects may occur in plasma
membrane; indeed, someG-protein-coupled receptors (GPCRs)
change the thickness of the membrane after ligand binding,
as reported by Salamon et al. for the mouse d-opioid receptor
(mDOR) in reconstituted membranes (10).
All of the biophysical approaches for quantifying these
general properties use model membranes with simple lipid
mixtures, whereas investigations on in vivo cell membranes
require indirect methods. Various ﬂuorescent membrane
probes, for example, the 1,6-diphenyl-1,3,5-hexatriene de-
rivatives (11) or prodan/laurdan probes (12), have been used
to determine membrane structure and lipid molecular orga-
nization. Another family of probes based on pyrene allows
the investigation of the lateral distribution and the dynamics
of membrane compounds (13). Indeed, the monomer (M)
and the excimer (E) species have different ﬂuorescence signals
(IM and IE, respectively) (13), and the ratio of ﬂuorescence
intensities (IE/IM) is directly related to the probe distribution
in the lipid membrane network (14). Moreover, pyrene is an
effective spectroscopic sensor of the polarity of the mem-
brane’s hydrophobic core (15): the monomer ﬂuorescence
spectrum consists of ﬁve emission bands, where I1 is a
function of the polarity of the probe’s surroundings and I3 is
mainly proportional to the probe’s concentration. Thus, the
ratio I1/I3 is of particular interest for membrane studies, be-
cause an increase in the mole fraction of cholesterol is cor-
related with a decrease of the membrane’s permeability to
water (16). Since the polarity within a lipid membrane is mostly
determined by the number of internal water molecules pres-
ent (17), the pyrene probe should report the cholesterol-
induced lo phase with respect to the ld phase.
In a previous study (18) of a cholesterol-pyrene-based probe
(1-pyrenemethyl-(3b)-3-hydroxy-22,23-bisnor-5-cholenate
(Py-ester-chol)), we identiﬁed several interesting properties
doi: 10.1529/biophysj.107.112821
Submitted May 15, 2007, and accepted for publication August 14, 2007.
Address reprint requests to Andre´ Lopez, Institut de Pharmacologie et de
Biologie Structurale, UMR 5089, 205 route de Narbonne, 31077 Toulouse
cedex, France. Tel.: 33(0)-561-175-945; Fax: 33(0)-561-175-994; E-mail:
andre.lopez@ipbs.fr.
This is an Open Access article distributed under the terms of the Creative
Commons-Attribution Noncommercial License (http://creativecommons.
org/licenses/by-nc/2.0/), which permits unrestricted noncommercial use,
distribution, and reproduction in any medium, provided the original work is
properly cited.
Editor: Thomas J. McIntosh.
 2007 by the Biophysical Society
0006-3495/07/12/4462/12 $2.00
4462 Biophysical Journal Volume 93 December 2007 4462–4473
of this probe family, but its low miscibility in lipid bilayers
made labeling living cell plasma membranes impossible. This
low miscibility was attributed to the polar atoms present in
the linker between the cholesterol moiety and the pyrene
moiety. To avoid this problem, we synthesized 3b-hydroxy-
pregn-5-ene-21-(1-methylpyrenyl)-20-methylidene (Py-met-
chol), a new probe designed without polar atoms in the linker.
We ﬁrst characterized its membrane behavior, and then used
absorbance measurements to study its lateral distribution in
model membranes. The ﬂuorescence experiments, carried out
with model membranes of various compositions, allowed us
to characterize changes in the core polarity and lipid organi-
zation, since both of these features are correlated with changes
in the membrane thickness. Finally, we used the probe to
label living cell plasma membranes and their ﬂuorescence
properties to detect the ﬁrst steps of a cell signaling pathway,
triggered by the thickness change associated with mDOR
binding its agonist (10).
MATERIALS AND METHODS
Organic synthesis of Py-met-chol
The scheme and the detailed description of the chemical synthesis, the
infrared, NMR 1H and 13C characteristics, the analytical characterizations,
and the RX molecular structure of tert-butyldimethylsilyl-(Py-met-chol) are
described in the Supplementary Material.
Lipids and other reagents
Cholesterol, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), and 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) were purchased from Sigma (St Louis,
MO), and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) was pur-
chased from Avanti Polar Lipids (Alabaster, AL). The purity of phospho-
lipids and sterols was conﬁrmed by thin-layer chromatography on silica-gel
(Merck, Darmstadt, Germany) using chloroform/methanol/water (65:25:4,
v/v) as the elution solvent. The detections were performed with the Dittmer’s
reagent for phosphorus compounds (19) and then heated to detect sterols.
Lipids, dissolved in chloroform/methanol (9:1, v/v) were stored at 4C be-
fore use. The concentrations of phospholipid solutions were determined by a
classical phosphate assay and by a colorimetric method (20) for cholesterol
and Py-met-chol. A gravimetric approach using a Sartorius (Goettingen,
Germany) super microbalance (107 g) was also used. Diprenorphin and
Deltorphin II were purchased from Sigma. Water was puriﬁed through a
Milli-Q system (Millipore, Bedford, MA).
Preparation of lipid vesicles
Liposomes were prepared by mixing appropriate volumes of the stock
solutions of phospholipids, cholesterol, or Py-met-chol (mole fractions
were calculated according to the total quantity of lipids in a given sus-
pension). Solvent was evaporated under a nitrogen stream and samples
were desiccated under vacuum for 2 h (1 Torr). The dried lipid samples were
hydrated in MOPS buffer (10 mM 3-morpholino-propanesulfonic acid, 100
mM NaCl, and 0.02% w/v NaN3, pH 7.4) and heated to 60C for 20 min
(this temperature is higher than the gel-to-liquid transition temperature
(Tm)). We immediately vortexed the sample for 4 min to allow the formation
of multilamellar vesicles (MLVs). For absorbance and ﬂuorescence experi-
ments, MLVs (at ﬁnal concentrations of 0.1–1 mM) were sonicated for 10
min at a temperature above the Tm using a VibraCell sonicator (Sonics &
Materials, Newtown, CT) with a titanium-plated tip delivering 12.5 W. The
samples, constituted of small unilamellar vesicle suspensions, were imme-
diately centrifuged for 25 min at 20,0003 g (5408R centrifuge, Eppendorf,
Hamburg, Germany) to remove any titanium particles. Small unilamellar
vesicle suspensions were stored for 36 h to allow vesicle fusion. The sizes of
relaxed large unilamellar vesicles (LUVs) were measured by dynamic light
scattering using a Dynapro device (Wyatt Technology, Santa Barbara, CA).
The LUVs in this study had a mean radius of 77 6 6 nm.
Differential scanning calorimetry
MLVs (at a ﬁnal concentration of 30 mM) were subjected to three cycles of
freezing and heating to 60C for 10 min for MLV homogenization. The
samples were stored at 4C for at least 24 h and then loaded into the sample
cell of the calorimeter; ;45 mg of each MLV suspension was sealed into a
stainless steel high-pressure capsule and scanned at rates of 600, 300, 150,
105, 60, 45, 30, and 15C/h from 5C to 60C and from 60C to 5C on a
Pyris-1 calorimeter (Perkin-Elmer, Norwalk, CT) (the reference was an
empty capsule). The amount of probe was maintained below its maximum
solubility in all cases. For all samples, we analyzed the scans to assess the
maximum temperature and the enthalpy of the gel-to-liquid phase transition
for each scanning rate. By extrapolation to 0C/h, we obtained the exact
melting enthalpy.
Absorption spectrometry
Absorption spectra were measured from 500 to 280 nm in a 1-cm path
length quartz cuvette using a Uvikon 923 spectrophotometer (Kontron
Instruments, Milan, Italy) equipped with a thermostated cuvette holder at
30 6 0.1C (Fisher Bioblock Scientiﬁc, Illkirch, France). We used air as
the reference to calibrate a zero baseline. The molar absorption coefﬁcients
of the probe emeas were calculated from the absorbance at 345 nm of each
liposome suspension. This corresponds to the lowest energy-absorption
band of the monosubstituted pyrene. To eliminate the effect of liposome
light scattering at this wavelength, we used a homemade program calcu-
lating the contribution of the turbidity (T(l)) to the absorbance spectrum of
each sample. This program is based on an equation (Eq. 1) modiﬁed from
that described previously (21):
TðlÞ ¼ A3 1
l
B1C; (1)
where l is the wavelength and A, B, and C are the parameters that have to be
ﬁtted. Using nonlinear regression, we determined the parameter values from
experimental measurements of absorbance at 290 nm and from 385 nm to
500 nm in a given sample. Thus, the turbidity value at 345 nmwas calculated
and allowed accurate measurement of the probe absorbance. We used the
Beer-Lambert law and these absorbance values to determine emeas values for
all samples.
Fluorescence spectrometry
Emission spectra were recorded on a QuantaMaster-4 spectroﬂuorimeter
(Photon Technology International, Birmingham, NJ) monitored by FeliX32
software. The excitation wavelength (bandwidth 5 nm) was set to 330 nm to
avoid the Raman peak of water. The ﬂuorescence emission (bandwidth 2
nm) was measured from 365 to 600 nm in 0.5-nm increments. The signal
integration time was set to 100 ms for vesicle suspensions and to 200 ms for
cell suspensions. Fluorescence spectra were recorded in 1-cm quartz
cuvettes thermostated at 37 6 0.1C (Fisher Bioblock Scientiﬁc) for LUVs
and labeled Chinese hamster ovary (CHO) cells. I1, I3, and IE were measured
at 376, 388, and 475 nm, respectively.
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Determination of the maximum solubility of
Py-met-chol in liposomes
We prepared POPC liposomes at a ﬁnal concentration of 0.1 mM with a
series of mole fractions of the probe (0.15–0.35 mol %). All probe molecules
not incorporated into liposomes formed aggregates in the buffer with a
speciﬁc spectral response. These aggregates were eliminated by centrifuga-
tion for 25 min at 20,000 3 g (5408R, Eppendorf). We then measured
(at 20C) the absorbance of each suspension at 345 nm as a function of
the mole fraction of the probe. The Py-met-chol mole fraction for which
the absorbance reached a plateau was taken as the maximum solubility.
Isodesmic model
Calculations were performed using the isodesmic model (18) described in
the Appendix. This model accounts for changes in the absorption (hypo-
chromism) of the probe’s pyrene moiety due to a self-association process in
membranes where the association constants, K, are equivalent for each
association step. The pyrene probe absorbs light as a monomer (emono) and as
n-mers, where the two pyrene molecules at the ends absorb light as half-
stacked mers (eext) and n-2 pyrene molecules inside an n-mer absorb light as
fully stacked mers (eint). For a given liposome suspension, the overall ab-
sorption (ecalc) corresponds to the sum of these three contributions weighted
by their respective mole fractions. Parameter ﬁtting (K, emono, eext, eint) is
performed by minimizing the sum of the squares of weighted residuals
(1=e2meas) between emeas and ecalc to account for the increased experimental
error as the probe concentration decreases.
Labeling mixture preparation
Methyl-b-cyclodextrin (MbCD, Sigma) was dissolved in water (683 mg in 7
mL) and heated to 70C under agitation. To obtain a 1:75 molar ratio (Py-
met-chol/MbCD), 50 mL of a solution of Py-met-chol in dimethylforma-
mide (138 mM) was added slowly. This solution was sterilized through a
0.22-mm-pore ﬁlter and stored for up to several weeks at 4C. The in-
cubation medium consisted of 1 mL of this solution diluted (1:30, v/v) in
phosphate-buffered saline (PBS) (Gibco-BRL, Cergy-Pontoise, France) and
warmed to 37C. The ﬁnal dimethylformamide concentration was ,0.05%.
The ﬁnal concentration of MbCD was 2.5 mM.
Cell culture and in vivo plasma membrane labeling
We used CHO cells stably transfected (CHO-d) with the gene for the mouse
d-opioid 7-transmembrane receptor (mDOR), which was produced at a rate
of 10 6 1 pmol receptor/mg protein. CHO wild-type cells (CHO-wt) were
used as controls. Cells were grown in culture ﬂasks in supplemented HAM-
F12 nutrient mixture (10% fetal calf serum, 2 mM sodium glutamate, 50 mg/
mL penicillin and streptomycin) at 37C under a 5% CO2 atmosphere.
Geneticin (0.8%, v/v) was added for selection of transfected cells. The cells
were plated on coverslips, washed twice with 1 mL of PBS without calcium
at 37C, and incubated with 1 mL of labeling mixture for 2 min at 37C. The
inoculum was removed and cells were washed six times with PBS without
calcium and then suspended in HEPES buffer (20 mM HEPES, 118 mM
choline chloride, 10 mM glucose, 3 mM MgSO4, 1.5 mM CaCl2, pH 7.4).
Four minutes later, we added an mDOR agonist (Deltorphin II) or antagonist
(Diprenorphin) to a ﬁnal concentration of 1 mM to the CHO or CHO-d cell
suspensions. All products were purchased from Gibco-BRL, Invitrogen.
Fluorescence imaging
Cells were covered with 60 mL of HEPES buffer and mounted on the
microscope. A Carl Zeiss Axioplan II microscope (Carl Zeiss Micro-
Imaging, Go¨ttingen, Germany) equipped with a 633 magniﬁcation oil-
immersion objective lens and a CCD camera C2400-75i (Hamamatsu
Photonics, Hamamatsu City, Japan) was used for wide-ﬁeld ﬂuorescence
imaging. The Zeiss Filterblock No. 01 (UV) was used. All measurements
were carried out at room temperature.
RESULTS
Py-met-chol was obtained by the condensation of
1-pyrenecarboxaldehyde and pregnenolone according to Scheme
1 in the Supplementary Material, which also describes the
organic synthesis and characteristics of all intermediary prod-
ucts, as well as the crystal data for tert-butyldimethylsilyl-
(Py-met-chol) (Supplementary Material, Fig. S1). The struc-
ture and the emission and excitation ﬂuorescence spectra of
Py-met-chol are shown in Fig. 1. All emission spectra re-
corded during this study were similar to the spectrum shown
in Fig. 1 b. The resolution and the wavelengths were un-
changed: I1 ¼ 376 nm, I3 ¼ 388 nm and IE ¼ 475 nm,
respectively.
To characterize the behavior of the pyrene probe in mem-
branes, we studied vesicles composed of phosphatidylcho-
lines (PC) with different acyl chains (DMPC, POPC, DOPC),
mixed with a series of mole fractions of cholesterol.
Py-met-chol maximum solubility
Wemeasured the maximum solubility of Py-met-chol in LUVs
composed of POPC at room temperature and compared it to
FIGURE 1 (a) Chemical structure of Py-met-chol (3b-hydroxy-pregn-5-
ene-21-(1-methylpyrenyl)-20-methylidene). (b) Emission (right) (lEm ¼
330 nm, bandwidth 2 nm) and excitation (left) (lEx ¼ 388 nm, bandwidth 2
nm) ﬂuorescence spectra in a bilayer: I1, I3, and IE were measured at 376,
388, and 475 nm, respectively.
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Py-ester-chol solubility and published results for cholesterol
(22). The saturation of phospholipids with Py-met-chol was
detected in absorption and ﬂuorescence spectra: Py-met-chol
aggregates in the buffer and leads to red-shifted absorption
and excitation spectra (23,24) (data not shown). These
aggregates were easily removed by centrifugation. Py-met-
chol inserted into POPC LUVs was thus quantiﬁed by
absorption measurements. We found that POPC LUVs are
saturated with 286 2 mol % of Py-met-chol at 20C, a much
higher value than for Py-ester-chol (;6 6 1 mol %) (18).
Comparison of the effects of cholesterol
and Py-met-chol on DPPC endotherms
We investigated by differential scanning calorimetry (DSC)
the effect of cholesterol and Py-met-chol on the modiﬁcation
of the phase physical properties of saturated-PC MLVs.
Representative DSC heating scans of aqueous multilamellar
suspensions of DPPC containing 0, 2.1, 5, 10, 15, and 20 mol
% of cholesterol or Py-met-chol are shown in Fig. 2, a and b.
Pure DPPC exhibited a classical endotherm similar to that
described in the literature (25): an endothermic pre-transition
at 36C followed by the main transition at 41.5C. The main
transition was abolished by 20 mol % of cholesterol and
by 15 mol % of Py-met-chol. The variations of the main tran-
sition melting enthalpies as a function of sterol contents
(0–20 mol %) revealed that the disturbance of the DPPC
melting enthalpy was similar for the two sterols (Fig. 2 c).
Self-association of Py-met-chol in
model membranes
We exploited the hypochromic behavior of pyrene to deter-
mine the lateral distribution of the ground-state Py-met-chol
in ﬂuid-phase LUVs according to the isodesmic self-associative
model (see Appendix) (18). The molar absorption coefﬁ-
cients emeas were determined from the maximum absorption
wavelength (corresponding to the lowest-energy band of the
allowed S0/ S2 pyrene transition: 345 nm) as a function of
the probe to host lipid mole fraction (0.01–5 mol %). Mea-
surements were made at 30C in DMPC, POPC, and DOPC
vesicles (characterized by different degrees of acyl-chain
unsaturation) and LUVs constituted by two DMPC/choles-
terol mixtures (85:15 and 70:30). Data and isodesmic ﬁts are
illustrated in Fig. 3. The emeas values for all liposome sus-
pensions were;32,000M1 cm1 at 1 mol % of Py-met-chol
and were little different at a probe mole fraction of 5 mol %.
However, when we lowered the probe mole fraction the emeas
values increased, indicating a hypochromic effect of the probe.
This effect was observed more sharply in LUVs composed of
unsaturated phospholipids. No shift of the maximum wave-
length of pyrene absorption was detected.
To quantify this phenomenon, we used the generic Eq. A12
of the isodesmic model to ﬁt the data and then determined the
self-association constant, K (M1) and the molar absorption
coefﬁcients emono, eint, and eext (M
1 cm1) corresponding
to the overall absorption process of these LUV suspensions
(Table 1). In each case, the self-association process led to the
formation of oligomers (n-mers) whose distribution and size
were calculated according to Eqs. A7 and A8 for a given K
value and various probes to host lipid mole fractions (CT).
This is illustrated in Fig. 4 using an association constant of
93 M1, corresponding to LUVs composed of pure DMPC:
the calculated distributions for n-mers up to heptamers are
shown. In Table 2 are reported, for the LUV suspensions
studied, 1), the calculated size of the most abundant n-mer
and the largest n-mer size (90% of probe molecules are
expected to be in n-mers of this size or smaller), for 2, 5, 20,
and 30 mol % of Py-met-chol; and 2), the percentages of the
monomers for 2 mol % Py-met-chol. We noticed that the
more the phospholipids are saturated, the more the probe was
distributed as monomer. Similarly, the amount of monomer
increased with the amount of cholesterol in DMPC.
FIGURE 2 (a and b) Representative raw DSC scans at 30C/h of DPPC
MLVs with various cholesterol (a) or Py-met-chol (b) mole fractions. DPPC
vesicles contained, from top to bottom, 0, 2.1, 5, 10, 15, and 20 mol %. The
stars indicate the pretransition peak of the pure DPPC MLVs. (c) Effect of
increasing amounts of cholesterol or Py-met-chol on the main-transition
chain melting enthalpy.
New Cholesterol-Pyrene Probe 4465
Biophysical Journal 93(12) 4462–4473
Fluorescence of Py-met-chol in model membranes
As cholesterol is able to induce a lo phase in some lipid
membranes, thereby increasing the membrane thickness, we
measured the ﬂuorescence emission spectra of Py-met-chol
in LUVs composed of DMPC, POPC, or DOPC with a series
of amounts of cholesterol.
The percentage of probe labeling
Fig. 5 a shows I3 and IE intensities as a function of the probe
mole fraction. A linear correlation between the probe quan-
tity and I3 was found in the concentration range of 0–1 mol
% when there were few excimers. For LUVs containing
.1 mol %, I3 diverged from the linearity as IE increased. We
then tested 0.2, 0.5, or 2 mol % of Py-met-chol in DMPC
with 0–55 mol % of cholesterol. The ﬂuorescence intensities
I1, I3, and IE were measured and the ratios I1/I3 and IE/I3
calculated (Fig. 5, b and c). The sample with 2 mol % of Py-
met-chol exhibited the maximum decrease of I1/I3 (30–35
mol % of cholesterol; Fig. 5 b), greater than that found for
higher probe concentrations (data not shown). Above this
mole fraction, I1/I3 increased with increasing cholesterol
mole fractions and joined the other I1/I3 values (0.2–0.5 mol
%). Similarly, IE/I3 only showed changes with the 2 mol %
sample (Fig. 5 c): a constant and low value of IE/I3 was
measured for mole fractions of cholesterol,30 mol %, but a
steep continuous increase was observed between 30 and 55
mol %. The sudden variations of I1/I3 and IE/I3 at probe
concentrations .30 mol % are due to the efﬁciency of the
excimer’s formation (see below). As excimer species are
only detected at.1 mol % of probe, 2 mol % of Py-met-chol
was used in the following experiments.
FIGURE 3 (a–c) Experimental data (dots) and corresponding isodesmic-
based ﬁts (lines) of Py-met-chol molar absorption coefﬁcient as a function of
probe mole fraction in LUVs of DMPC (a), POPC (b), and DOPC (c). (d)
Superimposition of ﬁtting curves. All measurements were performed above
Tm (30C). Error bars represent standard deviations of two independent
experiments.
FIGURE 4 Calculated evolution of monomer to heptamer species as a
function of Py-met-chol concentration in LUVs. We used an association
constant value of 93 M1, which corresponds to a DMPC environment.
Calculations were performed using the isodesmic model (see Appendix).
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Comparative study of DMPC, POPC, and DOPC
LUVs with various concentrations of cholesterol
and 2 mol % of Py-met-chol
In model membranes, cholesterol induces various lipid
organizations (lo versus ld phases), so we veriﬁed that the
probe was sensitive to these distinct membrane organiza-
tions. The normalized ﬂuorescence ratios I1/I3 and IE/I3 are
plotted against the mole fraction of cholesterol in Fig. 6, a
and b. Only DMPC showed a signiﬁcant decrease of I1/I3
until the mole fraction of cholesterol reached 30–35 mol %;
this was followed by a partial recovery for higher concen-
trations of cholesterol. In DOPC and POPC there was less of
a decrease. IE/I3 was unchanged in a range of 0–25 mol % of
cholesterol (Fig. 6 b), but showed a considerable increase
from 30 mol % in DMPC, a small increase from 45 mol % in
POPC, and no variation in DOPC. The main difference
between these LUVs containing 2 mol % of probe was that at
30 mol % of cholesterol and beyond, only DMPC is in lo
phase, whereas .45 mol % of cholesterol is needed for
POPC to display a lo phase. The lo lipid phase, its polarity
decrease (due to its being less permeable to water than the ld
phase), and the thickness increase were correlated (see
below).
Fluorescence of Py-met-chol in
plasma membranes
Py-met-chol was introduced into the plasma membrane of
living CHO cells using a MbCD-based protocol. This
protocol is easy to use, fast, and minimally disruptive.
Trypan blue was used to measure cell viability from 2 to 24 h
after cell labeling. Control and labeled cells multiplied and
survived similarly (data not shown), indicating that Py-met-
chol displayed no signiﬁcant toxicity for living cells. Fig. 7 a
shows a wide-ﬁeld microscope image of Py-met-chol-
labeled CHO-d cells. The corresponding cell suspension
ﬂuorescence spectrum is illustrated in Fig. 7 b and shows a
resolution comparable to that of LUV spectra. As deduced
from model membranes, a qualitative analysis of the amount
of inserted probe in the membrane is possible by considering
IE and IE/I3 values. Hence, the incubation time was adapted
to give cell ﬂuorescence spectra similar to those of liposomes
composed of POPC/30 mol % cholesterol and containing
2 mol % of Py-met-chol. Indeed, the initial IE/I3 value mea-
sured was 0.33 6 0.05 for all cell suspensions (Fig. 8 a)
close to the 0.30 6 0.01 obtained with POPC/30 mol % of
cholesterol LUVs (see Fig. 6 legend for other data values).
We monitored the plasma membrane thickness change
induced by agonist activation of mDOR (10). Fig. 8, a and
b, shows the variations of IE/I3 and I1/I3 for CHO-wt and
CHO-d cells as a function of time after addition of buffer,
Deltorphin II (mDOR agonist), or Diprenorphin (mDOR
antagonist). With CHO-d, a transient decrease of I1/I3 was
observed 2 min after agonist addition, reaching a maximum
magnitude after 4 min. Then, 2 min later, it had returned to
its initial value and remained constant. I1/I3 did not change
either in CHO-d cells after addition of antagonist or buffer in
CHO-wt (without mDOR) after agonist addition, showing
the speciﬁc Deltorphin II-induced effect. This result is
TABLE 1 Parameter values determined after data ﬁtting according to the isodesmic model
e (M1 cm1)
K (M1) (95% CI)* e mono (95% CI)* eext (95% CI)* eint (95% CI)* n
DOPC 669 (609–739) 143,510 (126,700–160,310) 70,750 (68,260–73,240) 31,360 (30,850–31,860) 33
POPC 281 (230–346) 77,270 (64,080–90,470) 61,860 (58,710–65,010) 31,020 (30,140–31,910) 31
DMPC 93 (84–103) 77,470 (74,260–80,690) 37,960 (36,750–39,170) 31,550 (31,030–32,070) 66
DMPC/chol (85:15) 68 (61–75) 74,450 (71,800–77,090) 34,940 (33,800–36,080) 31,220 (30,660–31,780) 36
DMPC/chol (70:30) 43 (38–49) 73,070 (71,350–73,780) 33,080 (32,300–33,870) 30,790 (29,360–31,200) 34
*Values in parentheses represent the 95% conﬁdence intervals (CI), calculated as follows: for a given parameter (K, emono, eint, or eext), with all others ﬁxed
equal to the solution. Consequently, the 95% CI value corresponds to the range where the given parameter reduces the error by ,5% (according to Fisher’s
test) on the 1/Y2-weighted residual sum of squares compared with the solution. e values are rounded to the nearest tenth. n, number of samples.
TABLE 2 Calculated n-mer distributions for various probe mole fractions and association constants in liposomes
Probe mole percentage (mol %)
K (M1) 2 2 5 20 30
Monomer (%) (Majority n-mer*/largest n-mery)
DOPC 669 5.7 (4/14) (6/22) (12/45) (14/55)
POPC 281 12 (2/9) (4/14) (8/29) (9 36)
DMPC 93 26 (1/5) (2/8) (4/16) (5/21)
DMPC/chol (85:15) 68 68 (1/4) (2/7) (4/14) (5/17)
DMPC/chol (70:30) 43 93 (1/3) (2/5) (3/11) (4/14)
*The majority n-mer is the one with the highest mole fraction in the liposome.
yThe largest n-mer size, describing 90% of probe molecules.
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strengthened by the observation of an absence of change
of I1/I3 and IE/I3 after addition of 1 mM of these ligands in
LUV suspensions of DMPC containing 0 or 30 mol % of
cholesterol and labeled with 2 mol % of Py-met-chol.
DISCUSSION
We report that Py-met-chol, owing to its structure, is much
more soluble than Py-ester-chol in model membranes.
Although this solubility is lower than that of cholesterol in
POPC (66 mol % (22)), our probe is able to label natural
membranes using MbCD. The low MbCD concentration
used (2.5 mM) is not sufﬁcient to induce cholesterol
depletion from the plasma membrane (26). Moreover, the
labeling conditions (only 2 min at 37C) are safe for living
cells. First, we compared the behavior of Py-met-chol and
cholesterol.
FIGURE 5 (a) Fluorescence intensities of the monomer (I3, 388 nm) and
the excimer (IE, 475 nm) as a function of Py-met-chol mole fraction, in
LUVs of DMPC. Fluorescence ratios I1/I3 (b) and IE/I3 (c) of Py-met-chol
incorporated at 0.2, 0.5, or 2 mol % in LUVs composed of DMPC as a
function of cholesterol mole fraction. Ratios are normalized taking ratio
values for suspensions without cholesterol as the reference, which
corresponded to I1/I3 and IE/I3 values of: 1.82 and 0.06 with 0.2 mol % of
Py-met-chol, 1.89 and 0.15 with 0.5 mol %, and 1.99 and 0.27 with 2 mol %.
Error bars represent standard deviations of two independent experiments. In
all cases, the temperature was 37C.
FIGURE 6 Fluorescence of Py-met-chol incorporated at 2 mol % in
LUVs of DMPC, POPC, and DOPC as a function of cholesterol mole
fraction. Evolution of I1/I3 (a) and IE/I3 (b) ratios of Py-met-chol are shown.
All measurements were performed at 37C. Ratios are normalized taking
ratio values for suspensions without cholesterol as the reference, which
corresponded to the following values for I1/I3 and IE/I3: 1.98 6 0.01 and
0.27 6 0.01 in DMPC, 1.99 6 0.01 and 0.30 6 0.01 in POPC, and
2.02 6 0.01 and 0.35 6 0.01 in DOPC.
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Biophysical behavior and absorbance properties
of Py-met-chol in model membranes
The effects of cholesterol and Py-met-chol on saturated
phosphatidylcholine MLV endotherms were determined.
DPPC was selected for the abundance and diversity of the
data in the literature. Tm (Fig. 2, a and b) changed slightly
when Py-met-chol replaced cholesterol (DT  4C and
1C, respectively, at 10 mol %). These decreases indicated
better sterol solubility in the ﬂuid phase than in the gel phase.
The broadening of the main transition peak revealed a lesser
DPPC melting cooperativity for Py-met-chol than for
cholesterol. The melting enthalpies of this transition de-
creased in a comparable way to, and linearly with, the mole
fractions of both cholesterol and Py-met-chol. These results
suggest that Py-met-chol/DPPC interactions are likely to be
determined by the cholesterol moiety of the probe. The
DPPC endotherms with 2.1 mol % of Py-met-chol were
comparable to those of DPHpPC, a probe known for its
limited disruptive effect on saturated PC (27). These various
ﬁndings indicate that the pyrene moiety has a little effect on
lipid membranes, especially if its concentration does not
exceed 2 mol %.
We determined the lateral distribution of Py-met-chol at
30C in the ground state by measuring the molar absorption
coefﬁcients, emeas, at the maximum absorption wavelength of
the S0 / S2 pyrene transition, as a function of the probe
concentration (18). A hypochromic effect was observed in all
LUV suspensions as the Py-met-chol concentration in-
creased. According to Todesco et al. (28), this suggests that
stacking of pyrene chromophore occurs and is a function of
the probe concentration. We used an isodesmic model to
estimate the self-association constants, K, and the theoretical
molar absorption coefﬁcients emono, eint, and eext. We found
that emono . eext . eint, and for the ﬁve distinct classes of
LUVs studied, eint values are in the same range. This leads to
converging emeas values (close to eint) in LUVs when the
probe concentration is .1 mol % (Fig. 3). The contribution
of emono is higher when the probe concentration is lower, but
emeas never reached values close to emono because this would
correspond to LUVs containing too few probe molecules to
be detected (i.e., probe concentration ,0.01 mol %).
Moreover, we report that KDOPC . KPOPC . KDMPC,
corresponding to increased probe self-association as the
degree of acyl-chain unsaturation increases. This effect is
comparable to the cholesterol interaction with phosphatidyl-
cholines, which is favored when acyl chains are saturated
(29). The calculations of n-mer distributions for various
percentages of Py-met-chol reveal the efﬁciency of this self-
associative process as assessed from the stack sizes: at 2 mol
% of probe, monomers were prevalent in DMPC, whereas
tetramers were the majority form in DOPC. Our ﬁndings
with DMPC liposomes containing 2 mol % of Py-met-chol
and mixed with 0, 15, or 30 mol % of cholesterol (Table 1)
show that K decreases as the cholesterol mole fraction
increases. This can be explained by better probe solvation in
DMPC/cholesterol than in pure DMPC LUVs. Indeed, we
found that for 2 mol % of probe, 93% of Py-met-chol
molecules were monomeric in DMPC/cholesterol (70:30)
LUVs, but only 26% were monomers in pure DMPC.
Previous studies analyzing cholesterol solubility in vari-
ous types of lipids have arrived at the same conclusion.
Effectively, the phase behavior of binary mixtures contain-
ing cholesterol and phospholipids indicated nonideal mixing
of cholesterol and the presence of ld/lo immiscibility regions
(30–32), and cholesterol promotes the lo domain (33).
Furthermore, the acyl-chain structure is known to affect
cholesterol interaction with lipids (34), causing variations in
cholesterol distribution andmembrane dynamics. Radhakrishnan
et al. (35) reported that there is less evidence for cholesterol
complex formation with unsaturated than with saturated PC.
This suggests that cholesterol is better solvated in saturated
than in unsaturated lipid environments where it is partially
excluded, implying formation of cholesterol oligomers rather
than monomers (34).
FIGURE 7 Fluorescence of Py-met-chol in living cells. (a) Wide-ﬁeld
microscope ﬂuorescence image of plasma membranes of CHO-d cells
incubated with Py-met-chol/MbCD for 2 min at 37C. The samples were
observed at room temperature. Scale bar, 10 mm. (b) Emission spectrum
of a CHO-d cell suspension at 37C labeled with Py-met-chol.
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Our results with Py-met-chol after absorption measurements
and isodesmic ﬁtting conﬁrm these ﬁndings for cholesterol,
with, in addition, a quantiﬁcation of the lateral distribution of
the probe. It may be possible to extrapolate this lateral dis-
tribution to that of cholesterol. Similar patterns for the lateral
distribution of cholesterol were proposed after dynamic sim-
ulations of particular lipid/cholesterol mixtures (36). Maze`res
et al. (37) used a similar experimental approach based on
pyrene-labeled phospholipids and reported weaker K values
(,1 M1) than those determined with Py-ester-chol (18) or
Py-met-chol (Table 1). These various results suggest that the
cholesterol moiety induces the stacking of cholesterol-pyrene
probe.
Fluorescence properties of Py-met-chol in
model membranes
Fluorescence measurements justiﬁed the choice of 2 mol %
for optimum labeling, because 1), this is near the limit of the
linear relationship between the ﬂuorescence monomer inten-
sity and the Py-met-chol concentration (Fig. 5); 2), it gen-
erates the largest amplitude of I1/I3 variations (Figs. 5 b and
6 a); and 3), it allows an accurate quantiﬁcation of the ex-
cimer (Fig. 5). Furthermore, absorbance ﬁndings show that
the most abundant n-mer is the monomer in DMPC samples
at 2 mol % of probe (Fig. 4 and Table 2), allowing an as-
sessment of membrane polarity (15,38).
We carried out ﬂuorescence studies of Py-met-chol in-
corporated into DMPC, POPC, and DOPC LUVs with a
series of concentrations of cholesterol (Fig. 6, a and b). A
correlation between the probe ﬂuorescence and the physical
properties of the membrane was observed. Note that at .30
mol % of cholesterol in DMPC, a full lo phase is present
(39); hence, the thickness of the membrane is maximum (9),
and the molecular protrusion of lipids is reduced (0.7 A˚ with
30 mol % of cholesterol and 2.7 A˚ in pure DMPC) (40). This
leads to a much lower polarity of the lipid core than the ld
phase, because the restricted conformational and rotational
motions do not allow the water to cross the membrane with
the same efﬁciency as in an ld lipid phase (41). This explains
our results with DMPC, where biphasic behavior is
observed: a decrease of I1/I3 until a full lo phase occurs,
followed by a recovery toward the POPC and DOPC I1/I3
values. These I1/I3 changes were not found with POPC or
DOPC. For DOPC, cholesterol is known not to promote a lo
phase but can induce only higher-order acyl chains (42). In
contrast, for POPC, a single lo phase should be present above
;45 mol % of cholesterol (43). Perhaps the small increase of
I1/I3 above 45 mol % of cholesterol (Fig. 6 a) reﬂects this
phenomenon. The same biphasic behavior is clearly ob-
served for IE/I3 with DMPC, whereas IE/I3 remains constant
in DOPC and increases very slightly in POPC (Fig. 6 b). In
all LUVs, from 0 to 25 mol % of cholesterol, IE/I3 values are
comparable but when the full lo phase is reached, an increase
is observed. This is a consequence of an increasing number
of monomers, as revealed by absorbance data (93% of
monomers versus 26% without cholesterol (see Table 2)),
inducing a more effective excimer formation (44). Indeed, as
reported in many studies, excimer formation is a dynamic
process and excimers are not formed from ground-state
oligomers in a bilayer (45). The increase of IE/I3 in the
DMPC lo phase as the cholesterol concentration increases
supports this statement. However, this effect is probably
slowed because the diffusion coefﬁcient of the lo phase is
smaller than that of the ld phase (46).
These various ﬁndings conﬁrm that 1), the probe has better
miscibility in the lo phase than in the ld phase; 2), the IE/I3
ratio can be used as an indicator to distinguish ld from full
lo phase in model membranes; and 3), I1/I3 is a sensitive
FIGURE 8 Fluorescence IE/I3 values of one set of various conditions (a)
and normalized I1/I3 values for all experiments (b) involving Py-met-chol
with living CHO-d and CHO-wt cell suspensions. The arrow indicates the
addition to the CHO-d cell suspension of a solution of buffer (HEPES,
n¼ 9), antagonist (Diprenorphin, n¼ 10), or agonist (Deltorphin II, n¼ 11),
or addition of a solution of agonist to the CHO-wt cell suspension (n ¼ 10).
I1/I3 ratios are normalized taking ratio values measured before ligand
addition. Error bars correspond to mean6 SE of n experiments. Agonist and
antagonist were used at ﬁnal concentrations of 1 mM. All measurements
were carried out at 37C. Lines are provided to facilitate reading.
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indicator of membrane polarity when ﬂuid ld and lo phases
coexist.
Fluorescence properties of Py-met-chol in the
plasma membrane of living cells
The ﬂuorescence spectra of Py-met-chol in living cell
membranes (Fig. 7 b) showed a resolution comparable to
those of LUVs (Fig. 1 b). An initial IE/I3 value of 0.33 6
0.05 conﬁrmed that the Py-met-chol quantity inserted into
cell plasma membranes was in accordance with our labeling
criterion. Nevertheless, initial I1/I3 values were in the range
of 2.15–2.30, and thus different from initial I1/I3 values of
LUVs containing 30 mol % of cholesterol (1.75–1.95). This
indicates that the probe environment inside the plasma
membrane is more polar than that inside model membranes.
This could be the result of polar atoms brought by transmem-
brane proteins into cell membranes.
Unlike LUVs, decreases of IE/I3 in living cells were
observed during the observation time. Indeed, in living cells,
endocytosis and exocytosis exchanges occur, leading to a
permanent efﬂux from the plasma membrane. However, this
decrease was greater in the CHO-d incubated with the agonist
(Fig. 8 a) than in controls, because a supplementary process
takes place: the internalization of the mDOR to regulate its
function (47).
The kinetics of I1/I3 variations revealed different behav-
iors according to cell stimulation (Fig. 8 b). Various ﬁndings
and concepts have to be considered to interpret these results.
Some GPCRs modify the thickness of the surrounding mem-
brane as part of their signaling function: rhodopsin and DOR
speciﬁcally change their transmembrane conformation after
agonist binding, as revealed by surface plasmon resonance
studies (10,48), inducing an increase in the transmembrane
thickness. These changes may induce a hydrophobic mis-
match between the protein and the surrounding lipids (49,50),
which could be a driving force for variations of local con-
centrations of particular lipids (including cholesterol), and
for thickness adaptations of lipid acyl chains (51). This thick-
ness increase inevitably reduces the water permeability and
the correlated intrinsic membrane polarity. By measuring Py-
met-chol I1/I3 ﬂuorescence, we observed a transient and
speciﬁc change with mDOR after agonist binding. The
timing of this biphasic I1/I3 change (a signal diminution for 4
min followed by a recovery to the initial value after 10 min),
is consistent with the characteristic times of two opposite
processes, the internalization (47) and recycling (52) mech-
anisms of mDOR. Note that with respect to the I1/I3 and IE/I3
variations in LUVs, which account for the entire membrane,
the variation in cells corresponded to membrane subfractions
occupied by the mDOR transmembrane protein.
We point out that our results were observed in living cells.
Furthermore, mDOR has been inserted in LUVs of deﬁned
compositions, but we were never able to reconstitute it in a
high-afﬁnity state to observe the binding of agonists, even
though this GPCR was characterized as inserted into the lipid
phase of these LUVs (data not shown). This underlines the
great difﬁculties encountered in reconstructing active GPCRs
in model membranes.
However, our observations conﬁrmed that Py-met-chol
ﬂuorescence measurements in living cells can be used as a
sensitive indicator to follow induced lipid organization changes.
In conclusion, we have synthesized a new ﬂuorescent
probe derived from cholesterol and have demonstrated that,
in membranes, it can 1), report on the lateral distribution of
cholesterol; 2), from I1/I3, measure polarity changes in the
hydrophobic core of model membranes; 3), from IE/I3,
characterize the lo phase in model membranes; and 4), reveal
lipid organization changes speciﬁcally induced by agonist
binding to mDOR. This new cholesterol-pyrene probe could
be used for screening analyses of new GPCR ligands in
living cells (53), when the transmembrane protein confor-
mational changes induced by their activation are comparable
to that of mDOR.
APPENDIX
Self-associative model (18): Assuming an inﬁnite linear self-association
scheme in which each step is characterized by the same equilibrium constant
K, only three kinds of contribution are expected to account for the absorption
properties of pyrene probes: the molar extinction coefﬁcients of free
monomers (emono), and, in a stack of n-mers, the contributions of both (n-2)
internal (eint) and the two external (eext) units. The calculated molar ab-
sorption coefﬁcient ecalc for a given probe concentration is:
ecalc ¼ amono3emono1aext3eext1aint3eint; (A1)
with amono1aext1aint ¼ 1 (A2)
where amono, aext, and aint are the molar fractions of free monomers and


















where [Pyi] is the molar fraction of n-mers consisting of i pyrene-probe
molecules, [Py1] is the molar fraction of monomer, and CT the probe/host





Accordingly, the equation used to calculate individual molar concentrations
of n-mers is
½Pyi ¼ i3Ki13 ½Py1i; (A7)
and so the relationship between CT, [Py1], and K can be interpreted as
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CT3 ð1 K3 ½Py1Þ2
; (A10)
and




CT3 ð1 K3 ½Py1Þ2
: (A11)
The generic equation of the isodesmic model is obtained by introducing the
Eqs. A8–A11 into Eq. A1, giving
ecalc ¼ fK; emono; eint; e ðCTÞext : (A12)
Knowing CT and using the above equations, we were able to calculate, by an
iterative process, amono, aext, and aint and determine the best values for the
various parameters—K, emono, eext, and eint—shown in Table 1. Equations
A7 and A8 led to descriptions of n-mer distributions as a function of the host
lipid/probe molar fractions shown in Fig. 4.
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